Increasing access to better and cheaper medicines and diagnostics for HIV/AIDS

Of the approximately 35 million people living with HIV today, sub-Saharan Africa is the most affected region, with 24.7 [23.5–26.1] million people living with HIV in 2013. Also sub-Saharan Africa accounts for almost 70% of the global total of new HIV infections.Over the last decade, smart investments have turned the tide on the HIV/AIDS epidemic in these countries. Millions of lives have been saved thanks to prevention, testing and treatment efforts. In 2013, 12.9 million people living with HIV were receiving antiretroviral therapy (ART) globally, of which 11.7 million were receiving ART in low- and middle-income countries. The 11.7 million people on ART represent 36% [34–38%] of the 32.6 [30.8–34.7] million people living with HIV in low- and middle-income countries. 

HIV Treatment

UNITAID has played a critical role in building this market by focusing on paediatric medicines, second-line medicines and integrated prevention of mother-to-child transmission of HIV. By intervening in these "niche markets", UNITAID has addressed gaps in global public health funding for HIV/AIDS treatment. Click below for an overview of our work in HIV treatments.
Read more

HIV Diagnostics – Point-of-Care and Decentralized Testing and Monitoring

In 2012, UNITAID announced the largest yet investment in point-of-care and decentralized HIV diagnostic products. Click below for more information on our work with HIV diagnostics.
Read more

Discover our individual HIV projects here:

Innovation in Paediatric Market Access (IPMA)


Stimulating and shaping the market for HIV self-testing in Africa

A Global Network to Improve Access and Quality of HIV Monitoring Technologies   Better HIV Treatment for Infants and Young Children

OPP-ERA Project   Oppositions Preventing Patent Barriers small banner

Accelerating Access to Innovative Point-of-Care HIV Diagnostics   Paediatric HIVAIDS Project

Implementation of CD4 and Viral Load Testing   making hiv treatment affordable in middle income countries small banner

Second-line Adult Antiretroviral Project    CPP-small
 Prevention of Mother-To-Child Transmission of HIV    ESTHERAID

Last updated June 2014